Reliance Chemotex Industries Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

Technical Trends Turn Bearish

The primary catalyst for the downgrade lies in the technical assessment, which has shifted from mildly bearish to outright bearish. Key technical indicators reveal a mixed but predominantly negative outlook. The Moving Average Convergence Divergence (MACD) shows a mildly bullish signal on the weekly chart but remains bearish on the monthly timeframe, indicating short-term momentum is insufficient to offset longer-term weakness.

Relative Strength Index (RSI) readings on both weekly and monthly charts offer no clear signals, suggesting a lack of directional conviction. Meanwhile, Bollinger Bands have turned bearish on the weekly scale and mildly bearish monthly, signalling increased volatility with downward pressure. Daily moving averages reinforce this bearish stance, confirming the stock’s price is trending below key averages.

Additional technical tools such as the Know Sure Thing (KST) indicator show mild bullishness weekly but bearishness monthly, while Dow Theory and On-Balance Volume (OBV) indicators reflect no trend or mild bearishness. Collectively, these metrics underscore a weakening technical foundation that has contributed significantly to the downgrade.

Financial Trend Remains Flat with Weak Growth

Reliance Chemotex’s recent quarterly financial performance has been largely flat, with Q3 FY25-26 net sales declining by 10.5% to ₹81.94 crores compared to the previous four-quarter average. This contraction highlights operational challenges amid a competitive textile industry backdrop. Over the last five years, the company’s net sales have grown at a modest annual rate of 7.89%, while operating profit has expanded at 19.57% annually, reflecting limited growth momentum.

Return on Capital Employed (ROCE), a key measure of operational efficiency, averages a weak 9.25%, underscoring the company’s struggle to generate adequate returns on invested capital. The debt servicing capacity is also concerning, with a high Debt to EBITDA ratio of 8.15 times, indicating significant leverage and potential financial strain.

Quality Metrics Signal Weak Long-Term Fundamentals

Long-term fundamental strength remains poor, as evidenced by consistent underperformance against benchmarks. The stock has generated a negative return of -25.12% over the past year, starkly contrasting with the Sensex’s positive 2.25% return in the same period. Over three years, Reliance Chemotex has delivered a -34.20% return, while the Sensex gained 27.17%, highlighting persistent underperformance.

Despite a five-year cumulative return of 57.06%, this marginally trails the Sensex’s 58.30%, and the 10-year return of 163.33% lags behind the Sensex’s 199.87%. These figures reflect a lack of sustained competitive advantage or growth leadership within the Garments & Apparels sector.

Valuation Appears Attractive but Reflects Underlying Risks

On valuation grounds, Reliance Chemotex presents a seemingly attractive profile with a low Enterprise Value to Capital Employed ratio of 0.9 and a ROCE of 4.5, suggesting the stock trades at a discount relative to its capital base. The Price/Earnings to Growth (PEG) ratio stands at a low 0.2, supported by a 101.1% rise in profits over the past year despite the stock’s negative price return.

However, this valuation discount is more indicative of the market pricing in the company’s weak fundamentals and technical deterioration rather than a genuine bargain. The micro-cap status and promoter majority ownership add layers of risk and illiquidity, which investors should carefully consider.

Market Price and Trading Range

As of 14 Apr 2026, Reliance Chemotex closed at ₹118.50, down 0.67% from the previous close of ₹119.30. The stock’s 52-week high stands at ₹211.65, while the 52-week low is ₹109.80, indicating a significant decline from its peak. Today’s trading range was between ₹113.25 and ₹118.50, reflecting moderate intraday volatility.

Comparative Performance Against Sensex

Short-term returns have been mixed, with the stock outperforming the Sensex over one week (+4.96% vs +3.70%) and one month (+6.85% vs +3.06%). However, year-to-date and longer-term returns reveal a stark underperformance. The stock’s YTD return is -11.20% compared to the Sensex’s -9.83%, and over one year, the stock has lost 25.12% while the Sensex gained 2.25%. Over three years, the divergence widens further, with Reliance Chemotex down 34.20% versus a 27.17% gain for the Sensex.

Summary of Ratings and Scores

MarketsMOJO’s latest assessment assigns Reliance Chemotex a Mojo Score of 26.0, reflecting a Strong Sell rating, downgraded from the previous Sell grade on 13 Apr 2026. The micro-cap classification and sector placement in Garments & Apparels contextualise the stock’s risk profile. The downgrade is primarily driven by deteriorating technical indicators, flat financial trends, weak long-term fundamentals, and valuation concerns despite some attractive metrics.

Investor Takeaway

Investors should exercise caution given the company’s weak financial performance, high leverage, and persistent underperformance relative to benchmarks. The bearish technical signals suggest limited near-term upside, while the valuation discount appears to reflect underlying risks rather than a value opportunity. Promoter majority ownership and micro-cap status add to the stock’s risk profile, making it less suitable for risk-averse or long-term growth-focused investors.

Overall, Reliance Chemotex Industries Ltd’s downgrade to Strong Sell signals a need for investors to reassess exposure and consider alternative opportunities within the Garments & Apparels sector or broader market.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today